RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Newsroom

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

Add as a preferred source on Google
Media Info

RTI International Media Relations:

As an independent, scientific research institute with a mission to improve the human condition, RTI International is engaged by clients and partners to conduct evidence-based research and project implementation. We share our work in line with journalistic and scientific standards and maintain a record in RTI’s Newsroom.

Measles outbreaks drive study of mothers’ decision-making about childhood vaccines

Share
Share on Facebook Share on X.com Share on LinkedIn Share via Email Print Page
Add as a preferred source on Google
Subscribe to